Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 14, 2025; 31(22): 101915
Published online Jun 14, 2025. doi: 10.3748/wjg.v31.i22.101915
Published online Jun 14, 2025. doi: 10.3748/wjg.v31.i22.101915
Table 2 Objective assessment of patients’ knowledge of ulcerative colitis, n (%)
Questions | Answers1 | |
Correct | Incorrect/don’t know | |
Are patients with UC frequently affected by joint pain and skin conditions? | 206 (41.1) | 295 (58.9) |
Do you know which part of your bowel is inflamed? | 430 (85.6) | 72 (14.4) |
Is UC an infectious disease? | 501 (99.6) | 2 (0.4) |
Is UC a mental illness? | 474 (94.9) | 25 (5.0) |
Is the immune system affected in UC? | 259 (51.7) | 242 (48.3) |
Is it useful to treat UC with immunosuppressants? | 229 (45.9) | 269 (54.1) |
Is there a special diet for UC? | 399 (79.8) | 101 (20.2) |
Do patients with UC have a lower risk for colorectal cancer than the general population? | 480 (95.6) | 22 (4.4) |
Is it possible to remove the entire colon without need for a permanent stoma? | 120 (24.1) | 377 (75.9) |
- Citation: Kruis W, Jessen P, Morgenstern J, Reimers B, Müller-Grage N, Bokemeyer B. Shared decision-making improves adherence to mesalamine in ulcerative colitis: A prospective, multicenter, non-interventional cohort study in Germany. World J Gastroenterol 2025; 31(22): 101915
- URL: https://www.wjgnet.com/1007-9327/full/v31/i22/101915.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i22.101915